GBIOGeneration Bio Co.

Nasdaq generationbio.com


$ 3.36 $ -0.02 (-0.59 %)    

Wednesday, 22-May-2024 15:59:58 EDT
QQQ $ 454.82 $ -0.09 (-0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -4.12 (-1.84 %)
$ 3.37
$ 3.19
$ 3.35 x 200
$ 0.00 x 0
$ 3.19 - $ 3.39
$ 0.86 - $ 6.98
136,714
na
223.88M
$ 1.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-generation-bio-maintains-10-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $10 price target.

 wedbush-reiterates-outperform-on-generation-bio-maintains-5-price-target

Wedbush analyst David Nierengarten reiterates Generation Bio (NASDAQ:GBIO) with a Outperform and maintains $5 price target.

 generation-bio-q1-2024-adj-eps-112-misses-041-estimate-sales-4059m-beat-1920m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(1.12) per share which missed the analyst consensus estimate of $(0....

 generation-bio-reports-presentation-of-preclinical-data-on-iqdna-and-ctlnp-platforms-at-asgct-27th-annual-meeting

Data included in the posters describe iqDNA as a modified, structured, partially single-stranded DNA that evades innate immunit...

 needham-reiterates-buy-on-generation-bio-maintains-10-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $10 price target.

 wedbush-reiterates-outperform-on-generation-bio-maintains-5-price-target

Wedbush analyst David Nierengarten reiterates Generation Bio (NASDAQ:GBIO) with a Outperform and maintains $5 price target.

 needham-maintains-buy-on-generation-bio-lowers-price-target-to-10

Needham analyst Gil Blum maintains Generation Bio (NASDAQ:GBIO) with a Buy and lowers the price target from $14 to $10.

 generation-bio-q4-eps-053-misses-045-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0....

 why-wynn-resorts-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

 wedbush-maintains-outperform-on-generation-bio-lowers-price-target-to-9

Wedbush analyst David Nierengarten maintains Generation Bio (NASDAQ:GBIO) with a Outperform and lowers the price target from...

 why-direct-digital-shares-are-trading-higher-by-around-33-here-are-20-stocks-moving-premarket

Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported better-th...

 generation-bio-q3-eps-043-beats-050-estimate-sales-215m-beat-109m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.50...

 jmp-securities-downgrades-generation-bio-to-market-perform

JMP Securities analyst Silvan Tuerkcan downgrades Generation Bio (NASDAQ:GBIO) from Market Outperform to Market Perform.

 top-4-health-care-stocks-that-may-rocket-higher-this-month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION